Gemfibrozil - Moligand™, 10mM in DMSO , Peroxisome proliferator-activated receptor alpha agonist, CAS No.25812-30-0, Peroxisome proliferator-activated receptor alpha agonist

CAS: 25812-30-0 Cat. No.: G408708 Fórmula: C15H22O3 Peso molecular: 250.33 Número CE: 247-280-2
Disponível para encomenda
GRAU & PUREZA Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10mM in DMSO
Synonyms
CI-719
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Tamanho
USA
Alemanha (EU)*
Preço
Qtd
1ml
G408708-1ml
2 Em stock
—
47,90US$
Enter a quantity for the sizes you want to add.

Visão geral

Information

Gemfibrozil (CI-719) is an activator of peroxisome proliferator-activated receptor-alpha (PPARα), used for the treatment of hypercholesterolemia and hypertriglyceridemia.
In vitro

Gemfibrozil exerts a minimal inhibitory effect on CYP3A-mediated simvastatin hydroxy acid (SVA) oxidation, but does inhibit SVA glucuronidation in dog and human liver microsomes. Gemfibrozil markedly inhibits M-23 formation, with a K(i) (IC(50)) value of 69 (95) mM, whereas inhibition of M-1 formation is weaker with a K(i) (IC(50)) value of 273 mM in human liver microsomes. Gemfibrozil strongly and competitively inhibits CYP2C9 activity, with a K(i) (IC(50)) value of 5.8 (9.6) mM. Gemfibrozil exhibits somewhat smaller inhibitory effects on CYP2C19 and CYP1A2 activities, with K(i) (IC(50)) values of 24 (47) mM and 82 (136) mM, respectively. Gemfibrozil, a lipid-lowering drug, inhibits cytokine-induced production of NO and the expression of inducible nitric-oxide synthase (iNOS) in human U373MG astroglial cells and primary astrocytes. Gemfibrozil induces peroxisome proliferator-responsive element (PPRE)-dependent luciferase activity, which is inhibited by the expression of DeltahPPAR-alpha, the dominant-negative mutant of human PPAR-alpha. Gemfibrozil strongly inhibits the activation of NF-kappaB, AP-1, and C/EBPbeta but not that of gamma-activation site (GAS) in cytokine-stimulated astroglial cells.

In vivo

Gemfibrozil treatment significantly reduces (2-3-fold) the plasma clearance of SVA and the biliary excretion of SVA glucuronide (together with its cyclization product SV), but not the excretion of a major oxidative metabolite of SVA in dogs.
Cell Data

cell lines:HCT116, NCI-H460, BRO, GRANTA-519, HL-60, THP-1, and Raji

Concentrations:

Incubation Time:

Powder Purity:≥99%

Especificações

Sinónimos
CI-719
Especificações e pureza
Moligand™, 10mM in DMSO
Mecanismos bioquímicos e fisiológicos
Gemfibrozil (CI-719) is an activator of peroxisome proliferator-activated receptor-alpha (PPARα), used for the treatment of hypercholesterolemia and hypertriglyceridemia.
Condições de armazenamento de armazenamento
Store at -80°C
Enviado em
Dry ice packs + Cold packs
Este produto requer transporte de cadeia fria. Serviços terrestres e outros serviços econômicos não estão disponíveis.
Grau
Moligand™
Tipo de ação
AGONIST, INHIBITOR
Mecanismo de ação
Peroxisome proliferator-activated receptor alpha agonist
Nomes e identificadores
SMILES isoméricas
CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
WGK Alemanha
3
RTECS
YV7120000
Peso molecular
250.33
Reaxys
1881200
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=1881200&ln=

Dados avançados

Alvos associados (humanos)
TTR Tclin Transthyretin (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PPARA Tclin Peroxisome proliferator-activated receptor alpha (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Certificados(CoA,COO,BSE/TSE e Mapa de Análise)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

1 results found

Lot NumberCertificate TypeDataItem
C2308520C2308520Certificate of AnalysisOct 16, 2026 G408708
Propriedades químicas e físicas
SolubilidadeSolubility (25°C) In vitro      
Ponto de ebulição (°C)159 °C/0.02 mmHg
Ponto de fusão (°C)61 °C
Segurança e perigos (GHS)
Pictograma(s)
GHS08,   GHS09,   GHS07
Sinal
Warning
Declarações de perigo

H351:Suspected of causing cancer

H411:Toxic to aquatic life with long lasting effects

H302:Harmful if swallowed

H361:Suspected of damaging fertility or the unborn child

Declarações de precaução

P273:Avoid release to the environment.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P405:Store locked up.

P501:Dispose of contents/container to an approved waste disposal plant.

P264:Wash hands [and …] thoroughly after handling.

P270:Do not eat, drink or smoke when using this product.

P391:Collect spillage.

P330:Rinse mouth.

P203:Obtain, read and follow all safety instructions before use.

P301+P317:IF SWALLOWED: Get medical help.

P318:if exposed or concerned, get medical advice.

WGK Alemanha
3
RTECS
YV7120000
Reaxys
1881200
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=1881200&ln=
Índice Merck
4388
FAQs e artigos
Citations of This Product
Calculadoras de soluções
Revisões

Avaliações dos Clientes

Deseja que lhe enviemos uma mensagem quando tivermos descontos disponíveis?

Lembrar-me mais tarde

Obrigado! Por favor, verifique a sua caixa de entrada de e-mail para confirmar.

Ops! As notificações estão desativadas.